Logo image
Prof. Dr. Jacob Schachter, Ph.D. working place, SHEBA Medical Center Ramat Gan
Prof. Dr. Jacob Schachter, Ph.D.
Excellent
AiroScore
9.80

Prof. Dr. Jacob Schachter, Ph.D.

oncology, skin cancer
oncology, skin cancer
User ScoreExperienceRatingPrice RangePublicationsOnline Consultations
94%38 years9.8/10$$$727No

Overview

Country, City
Israel, Ramat Gan
Health facility
SHEBA Medical Center Ramat Gan
Medical unit
Department of skin cancer and melanoma

About the doctor

Prof. Dr. Jacob Schachter, Ph. D. , is an esteemed oncologist specializing in skin cancer. With 37 years of experience, he is dedicated to providing the best care for his patients. Prof. Schachter obtained his medical license and completed his residency at prestigious medical institutions such as the Hebrew University of Jerusalem and the National Institutes of Health. He currently holds positions at the SHEBA Medical Center Ramat Gan, where he is the Chairman of the Department of skin cancer and melanoma, as well as a Senior Consultant at the Department of oncology of the Assuta Hospital. Prof. Schachter's expertise and dedication extend beyond his clinical work. He is a Lemelbaum Institute of Immuno-oncology founder and a professor at Tel-Aviv University. He is also actively involved in various professional organizations, serving as the head of the Israeli Melanoma Society and a member of the European Organization for the Research and Treatment of Cancer. With over 700 scientific publications, including studies on innovative treatments for melanoma, Prof. Schachter is at the forefront of cutting-edge research. His contributions to the field have significantly improved the survival rates and quality of life for patients with skin cancer. In summary, Prof. Dr. Jacob Schachter, Ph. D. , is a highly accomplished oncologist specializing in skin cancer. With a wealth of experience, he leads the Department of skin cancer and melanoma at the SHEBA Medical Center Ramat Gan and is actively involved in research and academia. Through his expertise and dedication, he continues to make significant contributions to the field of oncology, particularly in the treatment of melanoma.

Skills & Expertise

melanoma
metastatic melanoma
cancer
immunotherapy
pembrolizumab
pelvic
children
skin
carcinoma
genital tract
tumor
trametinib
dabrafenib
skin cancer
lymphogranuloma venereum
chemotherapy
squamous cell
squamous cell carcinoma
oncology
metastases
tumor infiltrating lymphocytes
uveal melanoma
lymph node
cervical neoplasia
sentinel node
melanoma cell
nk cells
ceacam1 melanoma
inflammation
breast cancer
cervix
lung cancer
skin barrier function
metastatic uveal melanoma
laryngeal cancer
skinrelated inflammatory
breast papillomas
cervical atypia
prostate tumors
mutationpositive melanoma
infection tumor
mucosal melanoma
solid tumors
genitalium
neck
cervical dysplasia
cervical cancer
colorectal cancer
mutated metastatic melanoma
metastatic breast cancer

Resume

CV (Curriculum Vitae)

Education
  • Studied human medicine at the Hebrew University of Jerusalem
  • Obtaining a license for medical practice
  • Residency at the Rabin Medical Center, Belinson campus
  • 1986 Residency at the National Institutes of Health – National Cancer Institute
  • Obtaining specialization in oncology
Experience
  • Department of the intensive care unit at the Medical Center of Ichilov Sourasky
  • Senior Consultant at the Department of oncology of the Assuta Hospital
  • Deputy Director of the Department of skin cancer and melanoma at the SHEBA Medical Center Ramat Gan
  • 2004 Chairman of the Department of skin cancer and melanoma at the SHEBA Medical Center Ramat Gan
  • Founder of the Lemelbaum Institute of Immuno-oncology
  • Professor at the Tel-Aviv University
Awards & Memberships
  • Head of the forum of the Israeli Melanoma Society
  • Member of the European Organization for the Research and Treatment of Cancer
  • Member of the Israeli Society for Oncology and Clinical Radiotherapy
  • Member of the Society for Biotherapy
  • Member of the early clinical study group

Languages

English flag
English
Hebrew flag
Hebrew

Publications

Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629.

9 November, 2023

Vitiligo induced by dupilumab treatment: A case series.

November, 2023

Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma.

31 August, 2023

FAQ

Where does the doctor practice?

What is the specialization of Prof. Dr. Jacob Schachter, Ph.D.?

The primary specialization of the doctor is oncology, skin cancer.

What is the experience of the specialist?

Prof. Dr. Jacob Schachter, Ph.D. has been practicing for more than 38 years.

What is the rating of the doctor?

What topics does Prof. Dr. Jacob Schachter, Ph.D. expert at?

The doctor has excellent knowledge in melanoma, metastatic melanoma, cancer, immunotherapy, pembrolizumab.

Is the specialist involved in the research?

Does the specialist offer online consultations?

No, Prof. Dr. Jacob Schachter, Ph.D. doesn’t perform virtual appointments.

Prof. Dr. Jacob Schachter, Ph.D.
Prof. Dr. Jacob Schachter, Ph.D.

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Prof. Dr. Jacob Schachter, Ph.D.

Similar Doctors

Dr. Raanan Berger, Ph.D.
Excellent
AiroScore
9.80
Prof. Dr. Amos Toren, Ph.D., MHA
Excellent
AiroScore
9.80
SHEBA Medical Center Ramat Gan
CAR T-cell therapy, hematology, and pediatric hemato-oncology
Dr. Elad Jacoby
Excellent
AiroScore
9.80
SHEBA Medical Center Ramat Gan
pediatric hematologist and oncologist
Dr. Talia Golan
Excellent
AiroScore
9.80
Dr. Dov Zippel
Excellent
AiroScore
9.80
SHEBA Medical Center Ramat Gan
general surgery and surgical oncology
Dr. Almog Ben-Yaacov
Excellent
AiroScore
9.80
SHEBA Medical Center Ramat Gan
general surgery and surgical oncology
Dr. Einav Nili Gal-Yam
Excellent
AiroScore
9.80
Dr. Zvi Symon
Excellent
AiroScore
9.80
SHEBA Medical Center Ramat Gan
internal medicine, general oncology, and radiotherapy